Basic information
- CAS
82964-04-3- Standard SMILES
COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F- InChIKey
LUBHDINQXIHVLS-UHFFFAOYSA-N- Molecular formula
- C16H14F3NO3S
- Average molar mass
- 357.3 g/mol
- Monoisotopic mass
- 357.06464897
Overview
Tolrestat is a member of naphthalenes. It has a role as an EC 1.1.1.21 (aldehyde reductase) inhibitor.
Names & identifiers
- Preferred name
- Tolrestat
- IUPAC
- 2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methylamino]acetic acid
- English name
- TOLRESTAT
- Molecular formula
- C16H14F3NO3S
- Molecular weight
- 357.35
Names & synonyms
Show more names
Database identifiers
- CAS
82964-04-3- PubChem CID
- 53359
- DTXSID
DTXSID80904890- ChEMBL
CHEMBL436- ChEBI
CHEBI:48549- UNII
- 0T93LG5NMK
- Nikkaji
- J23.281E
Properties
Computed structural properties
- XLogP
- 3.7
- Topological polar surface area
- 81.9 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 7
- Rotatable bonds
- 4
- Heavy atoms
- 24
- Formal charge
- 0
- Complexity
- 486
Experimental & physicochemical properties
Drugs
Pharmaceuticals -> Listed in ZINC15
Pharmaceuticals -> Alimentary tract and metabolism -> Drugs used in diabetes
Physicochemical properties
- Melting point
- 164 · 164-165°
- Boiling point
- 498.1 · 498.1±55.0 °C(Predicted)
- Density
- 1.399 · 1.399±0.06 g/cm3(Predicted)
- storage temp.
- 2 · 2-8°C
- solubility
- Chloroform (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly)
- form
- powder
- pka
- 3.49 · 3.49±0.10(Predicted)
- color
- white to beige
- InChI
- 1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22)
- InChIKey
- LUBHDINQXIHVLS-UHFFFAOYSA-N
- SMILES
- FC(F)(F)c1c2c(c(ccc2)C(=S)N(CC(=O)O)C)ccc1OC
- CAS DataBase Reference
- 82964 · 82964-04-3
- FDA UNII
- 0 T93LG5NMK · 0T93LG5NMK
- ATC code
- 10 XA01 · A10XA01
- UNSPSC Code
- 12352200 · 12352200
- NACRES
- 77 · NA.77
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 302 · H302-H315-H319-H332-H335
- Precautionary statements
- 261 · P261-P280-P305+P351+P338
- WGK Germany
- 3 · WGK 3
- Storage Class
- 11 · 11 - Combustible Solids
Safety & regulation
Toxicology
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Tolrestat
vMost-DILI-concern
8
Withdrawn
DOI:10.1016/j.drudis.2016.02.015
Safety data
- wgk
- WGK 3
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- Storage Class
- 11 - Combustible Solids
- Hazard statements
- H302-H315-H319-H332-H335
- Precautionary statements
- P261-P280-P305+P351+P338
Chemistry & industry
Pharmacology
ATC Code
A - Alimentary tract and metabolism
QA - Alimentary tract and metabolism
Applications
DescriptionTolrestat is a long-acting aldose reductase inhibitor reportedly useful in the prophylaxis of diabetic neuropathy, retinopathy and cataracts.
DescriptionTolrestat is an aldose reductase inhibitor (IC50 = 35 nM for the bovine lens enzyme). Dietary administration of tolrestat decreases sciatic nerve galactitol accumulation in a rat model of galactosemia (ED50 = 7.3 mg/kg per day) and sciatic nerve sorbitol accumulation (ED50 = 4.8 mg/kg per day) in a rat model of diabetes induced by streptozotocin (STZ; ). It also decreases urinary total protein exretion in a rat model of STZ-induced diabetes when administered at a dose of 25 mg/kg per day. Topical administration of tolrestat (2 and 3% in 10 μl four times per day) decreases levels of galactitol in the lens of and inhibits cataract formation in rats fed a high-galactose diet.
UsesTolrestat is an aldose reductase inhibitor.
UsesAlredase (Wyeth-Ayerst).
Upstream & downstream products
Upstream raw materials
Suppliers61 total
Additional notes
DefinitionChEBI: Tolrestat is a member of naphthalenes. It has a role as an EC 1.1.1.21 (aldehyde reductase) inhibitor.
Related reactions
Compound notes
Loading…